Cardio Diagnostics Holdings, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Cardio Diagnostics Holdings, Inc. on November 15, 2024. The filing details the voting results for four proposals submitted to shareholders. As of the record date (September 24, 2024), there were 25,905,656 shares of common stock eligible to vote, with approximately 55.51% represented at the meeting.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder votes. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the company's most recent 10-K or 10-Q filings for financial statements.
Material Changes and Voting Results
The following material actions were approved by shareholders:
- Election of Directors: Seven directors were elected to serve for the ensuing year. All nominees received a plurality of votes, though significant authority was withheld for some candidates (e.g., Warren Hosseinion had 1,885,711 votes withheld).
- Reverse Stock Split: Shareholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split between 1-for-5 and 1-for-40. This amendment will only be filed if the Board deems it necessary within one year.
- Share Issuance: Shareholders approved the future issuance of shares or convertible securities equal to 20% or more of outstanding common stock in non-public transactions, satisfying Nasdaq Listing Rule 5635(d).
- Auditor Ratification: The appointment of Prager Metis CPA's LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of specific risks or contingencies beyond the standard disclosures related to the proposed reverse stock split and share issuance. The reverse stock split is contingent on Board discretion and is not guaranteed to occur.
Key Facts for Investor Verification
- Verify the current status of the reverse stock split; approval was granted, but implementation is at the Board's discretion within one year.
- Review the definitive proxy statement (filed October 4, 2024) for detailed rationale behind the proposed share issuance and reverse split.
- Note the significant number of broker non-votes (6,014,546) on the director election and share issuance proposals, indicating a portion of shares held in street name were not voted on these specific items.
- Confirm the company's current financial position in separate filings, as this 8-K contains no financial data.